News

Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program

Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors

Burlington, Ontario--(Newsfile Corp. - April 1, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today...

Evolving Beyond the Expected: Advancing Diagnostics & Documentation for Eye Care Professionals with New Virtual Extraocular Motility (EOM) Exam

BROOKLYN, N.Y., April 1, 2025 /PRNewswire/ -- Virtual Field is proud to announce the launch of its new Extraocular Motility...

error: Content is protected !!